Utilization of Deworming Drugs and Its Individual and Community Level Predictors among Pregnant Married Women in Cameroon: A Multilevel Modeling

listen audio

Study Justification:
– Deworming pregnant women is an important strategy to reduce parasites and prevent anemia and related complications.
– However, the utilization of deworming medication among pregnant women in Cameroon is suboptimal.
– This study aims to assess the individual, household, and community-level factors associated with deworming medication utilization among pregnant married women in Cameroon.
– The findings of this study will provide valuable insights for policymakers and healthcare providers to improve deworming coverage and enhance the health outcomes of pregnant women in the country.
Highlights:
– The study used data from the 2018/19 Cameroon Demographic and Health Survey, which included a sample of 5,013 pregnant married women.
– The study found that about 29.8% of pregnant married women received deworming medications.
– Individual/household level predictors of deworming medication utilization included women’s educational level, wealth quintile, and skilled antenatal care.
– Community-level predictors of deworming medication utilization included distance to health facility and region.
– Pregnant married women who were educated, wealthier, had skilled antenatal care, or lived in the south region had higher odds of receiving deworming medication.
– Pregnant married women living in the north region had lower odds of receiving deworming medication.
– The study concludes that improving access to education and economic empowerment of pregnant married women in remote areas and the north region should be a priority for the Cameroon government to enhance deworming coverage.
Recommendations:
– The Cameroon government should focus on improving access to education for pregnant married women, especially in remote areas and the north region.
– Economic empowerment programs targeting pregnant married women in these areas should be implemented to improve their ability to access deworming medication.
– Efforts should be made to increase the availability and accessibility of skilled antenatal care services for pregnant women.
– Health facilities should be established or improved in areas with limited access to healthcare services.
– Awareness campaigns should be conducted to educate pregnant women and their families about the importance of deworming medication and its benefits.
Key Role Players:
– Cameroon government
– Ministry of Health
– Cameroon National Institute of Statistics
– United States Agency for International Development (USAID)
– ICF International
Cost Items for Planning Recommendations:
– Education programs for pregnant married women
– Economic empowerment programs
– Establishment or improvement of health facilities
– Skilled antenatal care services
– Awareness campaigns

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is based on a study using data from the 2018/19 Cameroon Demographic and Health Survey, which is a reliable source. The study used a large sample size of 5,013 pregnant married women and employed multilevel logistic regression analysis. However, the abstract does not provide specific details about the methodology used in the analysis, such as the specific variables included in the models and the statistical significance of the associations. To improve the evidence, the abstract should include more information about the methodology and provide specific results, including odds ratios and confidence intervals for the predictors of deworming medication utilization.

Background. Although deworming pregnant women is one of the strategies to reduce parasites (roundworms and hookworms) causing anemia and related perinatal and maternal complications, utilization of deworming medication among pregnant women in Cameroon is suboptimal. Comprehensive assessment of individual, household (including women’s autonomy), and community-level factors associated with utilization of deworming medication has not been done so far. Therefore, we investigated the individual/household and community-level factors associated with deworming among pregnant married women in Cameroon. Methods. Our study was limited to pregnant women because they have a greater risk due to increased chances of anemia. We used data from the 2018/19 Cameroon Demographic and Health Survey. Analysis on 5,013 pregnant married women was carried out using multilevel logistic regression. Odds ratios with a 95% confidence interval (CI) were reported. Results. Our findings showed that about 29.8% of pregnant married women received deworming medications. The individual/household level predictors of deworming medications utilization identified in this study were women’s educational level, wealth quintile, and skilled antenatal care. Distance to health facility and region were identified as community-level predictors of deworming medications utilization. Higher odds of receiving deworming medication occurred among educated and wealthier pregnant married women as well as among pregnant married women who had skilled antenatal care or lived in the south region, whereas lower odds were observed among pregnant married women living in the north region. Conclusion. Access to education and economic empowerment of pregnant married women in remote areas and the north region should be the primary focus of the Cameroon government to enhance deworming coverage in the country.

The data used for the analysis in this study were extracted from the 2018/19 Cameroon Demographic and Health Survey (CDHS), which is carried out by the Cameroon National Institute of Statistics (CNIS) in collaboration with the Ministry of Health (MOH) with financial and technical support from the United States Agency for International Development (USAID) and ICF International [38]. The CDHS collects data to produce evidence for monitoring vital population and several health indicators including utilization of deworming medications [38]. In the CDHS, the two-stage stratified cluster sampling technique was applied. In the first stage, primary sampling units (PSUs) or enumeration areas (EAs) were selected from the sampling frame, which was prepared from the recent population census using probability proportional to size [38]. In the second stage, a fixed number of households [25–30] were selected from the selected EAs using a systematic sampling technique [38]. A total of 14,677 women aged 15-49 and 6,978 men aged 15-64 were interviewed from 11,710 households [38]. Detailed descriptions of the methodology used in the survey are explained in the final report of the 2018/19 CDHS [38]. For this study, we used the Individual Recode (IR) file and limited the analysis to a sample of 5,013 pregnant married women. We used IR file because datasets for measuring women’s health indicators such as the utilization of deworming medication are found in that file [39]. In addition, we limited the study to married women because female empowerment factors such as decision-making power were confined to only married women [39–41]. Utilization of deworming medication was the outcome variable for this study. The WHO recommends that pregnant women take a single dose of mebendazole (500 mg) or albendazole (400 mg) after the second trimester [18]. The DHS asked pregnant women who took deworming medication with a birth in the last five years [18, 39, 42]. We categorized and coded responses to binary as “yes” if they took and “no” if they did not take the deworming medication. We incorporated several individual/household and community level explanatory variables based on available evidence on the uptake of deworming medication among pregnant women [19–25, 28, 43]. We incorporated the following individual/household level predictors and coded them as follows: maternal educational level (no education, primary, secondary, higher), husband’s educational level (no education, primary, secondary, higher), women’s occupation (not working, clerical, sales, agricultural self-employed, services, skilled manual, unskilled manual), husband’s occupation (not working, professional or technical or managerial, clerical, sales, agricultural self-employed, service, skilled manual, unskilled manual) religion (Catholic, Protestant, Other Christians, Muslim, Other), sex of household head (male, female), and skilled antenatal care (ANC) (no, yes). The wealth index was coded as poorest, poorer, middle, richer, and richest. In DHS, for measuring households’ economic status, the wealth index is usually computed using durable goods, household characteristics, and basic services following the methodology explained elsewhere [44], and we followed the same procedure. Regarding media exposure (yes, no), we coded yes if the women read newspaper, listened radio, or watched television for at least less than once a week, and no for otherwise. Women’s decision-making power was coded as yes versus no. If the women decided, either alone or together with their husband on all three of decision-making parameters; their own health, to purchase large household expenses, to visit families or relatives, the women considered as having decision-making power. However, if the woman did not decide, either alone or together with her husband, on at least one of the three abovementioned decision-making parameters, the woman was considered as having no decision-making power. The community-level factors included in this study were as follows: distance to health facility (big problem, not a big problem) place of residence (urban, rural), and region (Adamawa, Centre [without Yaoun], Douala, East, Far-North, Littoral [without Dou], North, North-West, West, South, South-West, Yaounde). Others were community literacy level (low, medium, high) and community socioeconomic status (low, moderate, high). In this study, a big problem indicates that the distance from women’s home to health facility (could it be a health center or hospital) to get medical help for herself was problematic. If the women responded as the distance was a big problem, we coded as 1 if the women reported as not a big problem and coded as 0 if the women were reported as a big problem. The socioeconomic status variable was an aggregation from occupation, wealth, and education of research participants who resided in a given community. We further applied principal component analysis to estimate women who were unemployed, uneducated, and poor. A standardized score was derived with a mean score (0) and standard deviation [1]. The scores were then segregated into tertile 1 (least disadvantaged), tertile 2, and tertile 3 (most disadvantaged), where the least score (tertile 1) denoted greater socioeconomic status and the highest score (tertile 3) denoting lower socioeconomic status. Community literacy level was derived from women who could read and write (or not read and write) at all. First, descriptive analysis including frequency distribution of respondents, utilization of deworming medication, and utilization across explanatory variables was conducted. Then, a chi-square test of independence was carried out to select variables that had a significant association with utilization of deworming medications at P value 0.05 cut point. Subsequently, a multicollinearity test was done using variance inflation factor (VIF) for all statistically significant variables at the chi-square test, and we found no evidence of high collinearity among the explanatory variables (Mean VIF = 1.71, Min VIF = 1.03, Max VIF = 3.51). Based on available evidence, a mean VIF less than 10 is acceptable [45, 46]. Finally, four different models were constructed using the multilevel logistic regression (MLLR) technique to assess whether or not the individual/household and community level predictors had significant associations with the outcome variable (utilization of deworming medication). The first model was a null model, which had no explanatory variables, and it displayed variance in the coverage of deworming medication, attributed to PSU. The second model called model I incorporated only the individual/household level predictors and the third model (Model II) included community-level predictors only. The final model, (Model III), comprised both the individual/household and community level predictors. All four MLLR models included fixed and random effects [47–49]. The fixed effects indicated the association between the explanatory variables and the outcome variable and the random effects signified measure of variation in the outcome variable based on PSU, which is measured by intracluster correlation (ICC) [50]. Finally, the model fitness, or how the different models were fitted with the data, was examined using Akaike’s Information Criterion (AIC) [51]. We used the “mlogit” command to run the MLLR models. Weighting was done to take into account the complex nature of DHS data, while the “svyset” command was used for adjusting for disproportionate sampling and nonresponse. The analysis was conducted using the Stata version-14 software (Stata Corp, College Station, Texas, USA). We used publicly available DHS data from MEASURE DHS for analysis of this study. Since the institution commissioned, funded, and managed the survey, further ethical clearance is not required. ICF international ensured that the protocol of the survey was compliant with the U.S. department of health and human service regulations to protect human subjects.

N/A

Based on the information provided, here are some potential innovations that could improve access to maternal health:

1. Mobile Health (mHealth) Solutions: Develop and implement mobile applications or text messaging services to provide pregnant women with information and reminders about deworming medication, antenatal care, and other important aspects of maternal health.

2. Community Health Workers: Train and deploy community health workers to educate pregnant women about the importance of deworming medication and provide them with access to these medications in their local communities.

3. Telemedicine: Establish telemedicine services to connect pregnant women in remote areas with healthcare professionals who can provide guidance and support regarding deworming medication and other maternal health concerns.

4. Public Awareness Campaigns: Launch targeted public awareness campaigns to increase knowledge and understanding among pregnant women and their families about the benefits of deworming medication and the importance of seeking antenatal care.

5. Strengthening Health Systems: Invest in improving healthcare infrastructure, particularly in rural and remote areas, to ensure that pregnant women have access to quality antenatal care and deworming medication.

6. Policy and Advocacy: Advocate for policies and regulations that prioritize and support the provision of deworming medication to pregnant women, especially those in underserved areas.

7. Partnerships and Collaboration: Foster partnerships between government agencies, non-governmental organizations, and private sector entities to leverage resources and expertise in order to improve access to deworming medication and other maternal health services.

It is important to note that these recommendations are based on the specific context of Cameroon and the findings of the study mentioned. The implementation of these innovations should be tailored to the local context and supported by further research and evaluation.
AI Innovations Description
Based on the information provided, the recommendation to improve access to maternal health is to focus on enhancing education and economic empowerment for pregnant married women in remote areas and the north region of Cameroon. This can be achieved through the following actions:

1. Education: Implement programs that promote education for pregnant married women, including initiatives to increase enrollment and retention rates. This can involve providing scholarships, improving school infrastructure, and addressing cultural barriers to education.

2. Economic Empowerment: Create opportunities for income generation and economic empowerment for pregnant married women. This can include vocational training programs, microfinance initiatives, and support for entrepreneurship.

3. Health Facility Accessibility: Improve access to health facilities by addressing the issue of distance. This can involve establishing mobile health clinics, improving transportation infrastructure, and providing incentives for healthcare professionals to work in remote areas.

4. Skilled Antenatal Care: Promote the utilization of skilled antenatal care services among pregnant married women. This can be achieved through awareness campaigns, training healthcare providers, and ensuring the availability of quality antenatal care services in all regions.

5. Community Engagement: Engage communities in promoting maternal health and deworming medication utilization. This can involve community education programs, involving community leaders and influencers, and addressing cultural beliefs and practices that may hinder access to maternal health services.

By implementing these recommendations, the government of Cameroon can improve access to maternal health and enhance deworming coverage for pregnant married women, ultimately reducing the risk of anemia and related perinatal and maternal complications.
AI Innovations Methodology
Based on the provided information, here are some potential recommendations to improve access to maternal health:

1. Increase awareness and education: Implement comprehensive education programs to raise awareness about the importance of maternal health and the benefits of deworming medication during pregnancy. This can be done through community health campaigns, antenatal care visits, and educational materials.

2. Strengthen antenatal care services: Improve the quality and accessibility of antenatal care services, ensuring that skilled healthcare providers are available to provide necessary care and information to pregnant women. This can include training healthcare workers, improving infrastructure, and ensuring the availability of essential medications and supplies.

3. Enhance women’s empowerment: Promote women’s empowerment by addressing socio-economic factors that limit access to maternal health services. This can be done through initiatives that focus on improving education, economic opportunities, and decision-making power for women.

4. Improve healthcare infrastructure: Invest in improving healthcare infrastructure, particularly in remote areas and regions with low access to maternal health services. This can include building and upgrading health facilities, ensuring the availability of essential equipment and medications, and improving transportation systems for pregnant women.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could be developed as follows:

1. Define indicators: Identify key indicators to measure the impact of the recommendations, such as the percentage of pregnant women receiving deworming medication, the percentage of women attending antenatal care visits, and the reduction in maternal and perinatal complications.

2. Data collection: Collect baseline data on the selected indicators from relevant sources, such as national health surveys, health facility records, and community-level assessments.

3. Develop a simulation model: Develop a simulation model that incorporates the identified recommendations and their potential impact on the selected indicators. This model should consider factors such as population demographics, healthcare infrastructure, and socio-economic conditions.

4. Input data and assumptions: Input the collected data into the simulation model, along with assumptions about the implementation of the recommendations. These assumptions could include the coverage and effectiveness of education programs, the availability of healthcare resources, and the timeline for implementation.

5. Run simulations: Run multiple simulations using different scenarios, varying the implementation strategies and assumptions. This will help assess the potential impact of each recommendation and identify the most effective combination of interventions.

6. Analyze results: Analyze the simulation results to determine the projected changes in the selected indicators. This analysis can provide insights into the potential improvements in access to maternal health and help prioritize interventions based on their expected impact.

7. Refine and validate the model: Continuously refine and validate the simulation model by incorporating new data, updating assumptions, and comparing the simulated results with real-world outcomes. This iterative process will improve the accuracy and reliability of the model over time.

By following this methodology, policymakers and healthcare stakeholders can gain valuable insights into the potential impact of different recommendations on improving access to maternal health. This information can guide decision-making and resource allocation to effectively address the challenges in maternal healthcare access.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email